Статья
Ex vivo Hsp70-activated NK cells in combination with PD-1 inhibition significantly increase overall survival in preclinical models of glioblastoma and lung cancer
2019-07-01
Shevtsov M., Stangl S., Edmond S., Lobinger D., Multhoff G., Galibin O., Khachatryan W., Pitkin E., Ischenko A. Ex vivo Hsp70-activated NK cells in combination with PD-1 inhibition significantly increase overall survival in preclinical models of glioblastoma and lung cancer. Frontiers in Immunology. 2019-07-01;10:454. https://doi.org/10.3389/fimmu.2019.00454
Цитирование
